3406 人次
LIVE CASE TRANSMISSION AND WHAT'S NEW (10月26日)
-
Hans-Reiner Figulla(University Jena) : TAVR for aortic regurgitation
-
Vaikom Mahedevan(Univesity of California San Francisco) : Non-invasive imaging pathways for coronary artery disease
-
Liwen Liu(The First Affiliated Hospital of Air Force Medical University (Xijing Hospital)) : A new technique for transthoracic treatment of HOCM
-
Maxim Itkin(University of Pennsylvania) : Lymphatic interventions for complications of congenital heart diseases
-
Frank Ing(University of California – Davis) : Recanalization of chronically occluded veins
-
James Thompson(Inova Heart and Vascular Institute) : Live transmission from Inova Heart and Vascular Institute, Falls Church, Virginia
MITRAL VALVE REPAIR AND REPLACEMENT (10月26日)
-
Vaikom Mahadevan(University of California San Francisco) : Mitral valve in MAC: patient selection and how to do it
-
Jacob Mishell(Kaiser Permanente San Francisco Medical Center) : Mitral edge-to-edge repair for FMR – Update on clinical trials
-
Marvin Eng(Henry Ford Health System) : Initial experience with PASCAL
-
Mark Reisman(University of Washington Medical Center) : Initial experience with the new Mitraclip
-
Eberhard Grube(Heart Center Bonn) : Update on transcatheter mitral annuloplasty techniques
-
Brian Whisenant(Intermountain Heart Institute) : Cardioband
-
Horst Sievert(Cardiovascular Center Frankfurt) : Deep dive into first and only blinded randomized trial in mitral valve repair
-
Danny Dvir(University of Washington Medical Center) : Mitral valve in valve and valve in ring: my 10 most important tips and tricks
-
Eberhard Grube(Heart Center Bonn) : Early results with dedicated mitral valves
TAVR (10月26日)
-
Stefan Bertog(Minneapolis Veterans Affairs Medical Center) : Live transmission from Minneapolis Veterans Affairs Medical Center,Minneapolis, USA
-
Rajendra Makkar(Cedars-Sinai Medical Center) : TAVR for younger and low risk patients: what are the concerns?
-
Pro and con of embolic protection as a standard for TAVR
-
Eberhard Grube(Heart Center Bonn) : Pro
-
Brian Whisenant(Intermountain Heart Institute) : Con
-
Suneet Mittal(Valley Health System) : When should RV pacing be performed for TAVR?
-
New valves:
-
Rahul Sharma(Cedars-Sinai Medical Center) : Centera Valve
-
Tarun Chakravarty(Cedars-Sinai Medical Center) : New valves-New Lotus
-
Eberhard Grube(Heart Center Bonn) : Other new valves
-
Rajendra Makkar(Cedars-Sinai Medical Center) : Best strategy to prevent leaflet thrombosis
-
Eberhard Grube(Heart Center Bonn) : Minimalist approach – Pro and con
-
Kirsten Tolstrup(University of California San Francisco) : Is there a role for TEE in TAVR
-
Horst Sievert(National Centre for Cardiovascular Diseases) : Strategy for bicuspid aortic valve diseases - Experiences from China
-
Horst Sievert(Cardiovascular Center Frankfurt) : The PerQSeal closure device
Live Only (10月26日)
-
Live transmission from:
-
Rajendra Makkar(Cedars-Sinai Medical Center) : Cedars Sinai Medical Center, Los Angeles, USA
-
Stefan Bertog(Minneapolis Medical Center) : Minneapolis Veterans Affairs Medical Center, Minneapolis, USA
-
James Thompson(Inova Heart and Vascular Institute) : Inova Heart and Vascular Institute, Virginia, USA
STROKE DETECTION AND PREVENTION OPTIONS (10月27日)
-
Wade Smith(University of California San Francisco) : The diagnosis of ischemic and cryptogenic stroke
-
Mintu Turakhia(Stanford University Stanford) : Prevalence of ICH and role of OAC in preventing ischemic stroke
-
Michel Barakat(Health University of Utha) : Role of atrial fibrosis in stroke and AF
-
Gregory Marcus(University of California San Francisco) : AF Monitoring devices – What information do they provide for strokeprevention
-
James Cox(Northwestern University Chicago) : Can sinus rhythm be obtained in persistent and longstanding persistent AF?Implications for stroke prevention
-
David Wilber(Loyola University Medical Center Hines) : Implication of AF ablation studies? (Crystal AF, aMAZE, Cabanan, East)
INTERVENTIONS FOR STROKE PREVENTION: ARE THE DATA CONVINCING? (10月27日)
-
Maurice Buchbinder(San Diego Cardiovascular Associates Foundation for Cardiovascular Medicine) : Rationale for LAA occlusion in the prevention of stroke – Efficacy, safety and cost benefits
-
Jonathan Hsu(University of California San Diego) : Should an epicardial LAA approach be considered in patients with contraindications to OAC therapy?
-
John Carroll(University of Colorado Hospital) : PFO closure: the long journey from experimental medicine to a class IArecommendation
-
James Freeman(Yale University) : Should LAA closure be performed routinely during surgery? Impact on stroke
-
Guy Shinar(Javelin Medical) : A new minimally invasive concept for permanent stroke prevention
CONTROVERSIES IN STROKE PREVENTION AND ARRHYTHMIAS (10月27日)
-
Horst Sievert(Cardiovascular Center Frankfurt) : Recorded case: PFO closure with Amplatzer PFO occluder - step by step
-
David Wilber(Loyola University Medical Center) : How do you prevent stroke in the anticoagulation contraindicated patient?
-
David Holmes(Mayo Clinic) : How serious is device related thrombus? Real life perspective.
-
James Cox(Northwestern University) : LAA closure and leaks: What is the significance?
-
Edward Gerstenfeld(University of California San Francisco) : Should AF ablation be used to prevent CHF?
-
Byron Lee(University of California San Francisco) : Vest predicts: what did we learn?
-
Mark La Meir(Academic Hospital Maastricht) : Surgical Treatment of inappropriate sinus tachycardia and POTTS syndrome
-
Jayanthi Koneru(VCU Health) : His Bundle pacing instead of CRT?
KEYNOTE LECTURES (10月27日)
-
Yuval Binur(Arsuf Partners) : CV innovations - where are we heading to in the changing world
-
Peter Fitzgerald(Stanford University) : What could be the next really ground breaking innovations in cardiovascularmedicine?
WHY CLOSE THE LAA – CONVENTIONAL AND EXPANDED INDICATIONS (10月27日)
-
Vijay Swarup(Arizona Heart Rhythm Center) : Live transmission from Arizona Heart Rhythm Center, Phoenix, USA
-
Krzysztof Bartus(Jagiellonian University) : LAA closure with LARIAT: influence on hormonal regulation and coagulation
-
David Holmes(Mayo Clinic) : Real World Experience for LAA closure
-
Michael Hoskins(Emory Heart & Vascular Center at Clifton) : Does LAA closure for the treatment of AF make sense?
-
Jonathan Hsu(University of California San Diego) : Is there a role for LAA closure devices and low dose OAC therapy?
-
Jacqueline Saw(Vancouver General Hospital) : LAA US trials: Ongoing and future trials
-
Randall Lee(University of California San Francisco) : Case presentations of different LAA cases – Determination of the optimal LAA closure device
PFO CLOSURE (10月27日)
-
Karl Meisel(University of California San Francisco) : A deep dive into the Amplatzer PFO trials
-
Matthew Price(Scripps Clinic) : REDUCE deep dive
-
Debate: size of PFO and right to left shunt ….
-
John Rhodes(Medical University of South Carolina), Jr. : matters
-
Matthew Price(Scripps Clinic) : doesn’t matter
-
Matthew Price(Scripps Clinic) : Atrial fibrillation after PFO closure: how frequent? How to deal with it? What isthe prognosis?
-
John Rhodes(Medical University of South Carolina), Jr. : CARDIOFORM vs. Helex closure rate
-
Keshav Nayak(Naval Medical Center San Diego) : Should we close PFOs in divers before something happens?
SHARK TANK (non CME accredited) (10月27日)
CLOSING REMARKS (10月27日)
Series
- Webcast | CSI Webinar:Access to the heart
- Webcast | CSI Webinar:Pulmonary valve implantation
- Webcast | CSI Webinar:ASD CLOSURE
- Webcast | CSI Webinar:Sinus Venosus ASD Closure
- Webcast | CSI CATHLAB LIVE: LIVE CASE TRANSMISSIONS
- Webcast | CSI Webinar:LAA CLOSURE: PRE-PROCEDURAL PLANNING AND IMAGING
- Webcast | CSI Webinar:TRICUSPID VALVE INTERVENTIONS
- Webcast | CSI Webinar—NEW DEVICE THERAPIES FOR HEART FAILURE
- Webcast | CSI Webinar:MITRAL VALVE INTERVENTIONS
- Webcast | CSI CATHLAB LIVE: LIVE CASE TRANSMISSIONS
- Webcast | CSI Webinar: Mitral paravalar leaks
- Webcast | CSI FOCUS D-HF: RIGHT HEART FAILURE
- Webcast | CSI FOCUS D-HF: Valve interventions in patients with HEART FAILURE
- Webcast | CSI Webinar: Fontan circulation interventions
- Webcast | CSI FOCUS D-HF: THE FUTURE OF DEVICE-BASED THERAPIES AND DIAGNOSTICS FOR HEART FAILURE: THE CMO VIEW
- Webcast | CSI FOCUS D-HF: NEW AND UPCOMING DEVICES AND CONCEPTS FOR HEART FAILURE
- Webcast | CSI FOCUS D-HF: Mechanical circulatory
- Webcast | CSI FOCUS D-HF: Neuromodulation in the management of heart failure and its comorbidities: diabetes, sleep apnea and hypertension
- Webcast | CSI Focus LAA: New and upcoming devices for LAA closure
- Webcast | CSI webinar: Sinus venosus ASDs
- Webcast | CSI Webinar—NEIL WILSON’S CHALLENGING CASES
- Webcast | CSI Webinar—Biodegradable devices
- Webcast | CSI Webinar—20-Year Journey with Melody TPV: Experience & Insights
- Webcast | CSI FOCUS LAA: Masterclass - OMEGA
- Webcast |CSI Webinar—Tricuspid valve interventions
- Webcast | CSI Focus LAA: Anatomy and Imaging
- Webcast | CSI Webinar—Pulmonary valve interventions
- Webcast | CSI Webinar—VSD closure
- Webcast | CSI Webinar—Mitral valve interventions
- Webcast | CSI Webinar—WHAT´S NEW IN STRUCTURAL INTERVENTIONS
- Webcast | CSI Webinar—LAA CLOSURE
- Webcast | CSI Webinar—What's new in imaging
- Webcast | CSI Frankfurt 2019
- Webcast | CSI Asia-Pacific 2019
- Webcast|CSI-Focus LAA
- Webcast | CSI Frankfurt 2018 on congenital, structural and valvar percutaneous heart interventions